ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,269,728 | -49.9% | 400,545 | -21.5% | 0.01% | -50.0% |
| Q2 2023 | $2,534,968 | -47.7% | 510,054 | -48.0% | 0.01% | -50.0% |
| Q1 2023 | $4,849,440 | -26.2% | 981,668 | -6.0% | 0.02% | -35.1% |
| Q4 2022 | $6,568,842 | -22.9% | 1,044,331 | +32.3% | 0.04% | -19.6% |
| Q3 2022 | $8,524,000 | -11.4% | 789,273 | -6.5% | 0.05% | -8.0% |
| Q2 2022 | $9,620,000 | +33.1% | 843,861 | +6.3% | 0.05% | +22.0% |
| Q1 2022 | $7,229,000 | +72.2% | 793,495 | +182.0% | 0.04% | +78.3% |
| Q4 2021 | $4,198,000 | +225.4% | 281,386 | +450.8% | 0.02% | +109.1% |
| Q4 2020 | $1,290,000 | -70.6% | 51,091 | -56.1% | 0.01% | -70.3% |
| Q3 2020 | $4,387,000 | -48.3% | 116,345 | -41.3% | 0.04% | -61.9% |
| Q2 2020 | $8,488,000 | – | 198,221 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |